Description
A local research facility is seeking participants aged 18-80 for a clinical research study on NASH and Fibrosis. This study is evaluating an investigational injectable drug, efruxifermin, compared to placebo in the treatment of patients who have been diagnosed with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and fibrosis.
Trial-related procedures and study medication will be provided at no cost.
Space is limited, subject to availability. Criteria for qualification are subject to change at any time and without notice.
National
Posted: 06/04/25
up to $50
